HCRN-LUN88-6
Phase II Trial of Daily Oral Etoposide in Advanced Non-Small Cell Lung Cancer
HCRN-GU98-1
Phase II Study of Vinorelbine plus Estramustine in Metastatic Hormone-Refractory Prostate Cancer
HCRN-BRE94-1
A Hoosier Oncology Group Phase II Study of Biweekly Cisplatin (C) and Paclitaxel (P) in the Treatment of Metastatic Breast Cancer: A Hoosier Oncology Group (HOG) and Walther Cancer Institute Trial BRE94-1
HCRN-GU00-13
A Phase II Study of ALIMTA in Patients With Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
HCRN-GI00-2
A Phase II Trial of Irinotecan (CPT-11), 5-Fluorouracil (5-FU), Glutamine, Leucovorin and Celecoxib as First Line Therapy for Metastatic Colorectal Cancer –GI00-2
HCRN-CLL03-59
A Phase II Study of Ontak in Patients with Previously Treated Chronic Lymphocytic Leukemia
HCRN-QL00-4
A Phase I Trial of Olanzapine (Zyprexa) For the Prevention of Delayed Emesis In Cancer Patients Receiving Chemotherapy
GYN03-62
Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62
HCRN-LUN88-4
Phase II Trial of Daily Oral Etoposide in Refractory Small Cell Lung Cancer
HCRN-BRE93-1
A Phase II Study of Oral Etoposide and Ifosfamide in the Treatment of Patients with Stage IV Breast Cancer
HCRN-GU97-1
Phase II Study of Diethylstilbestrol in Metastatic Prostate Cancer
HCRN-MM02-35
A Phase II Study of Bisphosphonate: Zoledronic Acid (Zometa) in the Management of Asymptomatic/Early Stage Multiple Myeloma
HCRN-MEL90-1
Phase II Trial of Carboplatin plus Interferon Alpha-2a in Metastatic Melanoma
HCRN-LUN88-3
Phase III Study of VP-16 + Cisplatin Alone (VP) + Ifosfamide (VIP) for Previously Untreated Extensive Small Cell Lung Cancer
HCRN-GI02-38
A Phase II Study of Capecitabine plus Docetaxel Combination in Patients with Esophageal/Gastric Cancer
HCRN-BRE92-1
A Phase III Study of Pre-Operative Chemotherapy, Cytoxan, Adria, 5-FU vs HD Adria, Cytoxan and G-CSF for Breast Cancer not Considered Candidates for Lumpectomy
HCRN-MM01-21
A Phase II Study of Daily Thalidomide, Oral Cytoxan and Prednisone for Relapsed or Refractory Multiple Myeloma
HCRN-GI89-2
Phase II Study of 5-FU and Leucovorin + Radiation in Pancreatic Cancer
HCRN-GYN97-2
A Phase II Trial of Pre-operative Pelvic and Para-Aortic Radiotherapy and Radical Pelvic Surgery in Stages IIIB and IVA Carcinoma of the Cervix
BNK09-138
A Biological Sample Collection Protocol of Patients with and without Metastatic Solid Organ Malignancies
HCRN-GU88-1
Phase II Study of Vinblastine + Dipyridamole for Metastatic Renal Cell Carcinoma
HCRN-GU14-206
A phase II single arm multi-center trial evaluating the efficacy of pembrolizumab in the treatment of patients with incurable platinum refractory germ cell tumors
HCRN-MEL89-1
Phase II Study of Daily Oral VP-16 in Previously Untreated Melanoma
HCRN-SAR90-1
Phase II Trial of Daily Oral Etoposide in Advanced Sarcoma
GI06-101
Phase II Trial of Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas: Hoosier Oncology Group GI06-101
HCRN-GU93-1
A Phase III Study of Vinblastine vs Vinblastine plus Estramustine for Metastatic Hormone Refractory Prostatic Cancer
HCRN-GYN98-1
A Phase II Trial of Ifosfamide and Oral Etoposide For Refractory Ovarian Cancer
HCRN-MDS98-1
A Phase II Trial of Topotecan in Patients With Myelodysplastic Syndrome
HCRN-QL97-1
Fluoxetine Versus Placebo in Advanced Cancer Outpatients: A Randomized, Double-Blind, Placebo-Controlled Trial
HCRN-BRE89-1
Carboplatin and WR-2721 as First-Line Chemotherapy for Metastatic Breast Cancer (MBC): A Hoosier Oncology Group Study BRE89-1
HCRN-GYN97-1
A Phase II Study of Intraperitoneal 32p and Vaginal Brachytherapy in the Treatment of Papillary Serous and Clear Cell Adenocarcinoma of the Endometrium
HCRN-GI89-1
A Randomized Phase III Study of 5-Fluorouracil vs 5-Fluorouracil + Levamisole in Previously Untreated Metastatic Colon Cancer – GI89-1
HCRN-LUN87-1
A Phase II Trial of VP-16, Ifosfamide and Cisplatin (VIP) Combination Chemotherapy for Previously Untreated Extensive Small Cell Lung Cancer
HCRN-HN90-1
Phase II Trial of Interferon Alpha-2b plus Cisplatin and 5-FU in Recurrent or Metastatic Head and Neck Cancer
HCRN-NHL00-1
A Phase II Study of Single Agent Gemcitabine In Relapsed or Refractory Follicular or Small Lymphocytic Non-Hodgkin’s Lymphoma
HCRN-HOG-06
A Randomized Phase III Study of Low-Dose Cytosine Arabinoside vs Supportive Care in the Treatment of Preleukemia
HCRN-GI00-16
A Phase II Study of Cisplatin, 5-Fluorouracil (5-FU), Radiation Therapy and Celecoxib for Resectable Esophageal Cancer – HOG GI 00-16
HCRN-GU98-2
Weekly Paclitaxel and Gemcitabine in Advanced Transitional Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study
HCRN-HOG89-1
Carboplatin in Hypercalcemia
HCRN-GU90-2
Phase II Study of Flutamide Plus Interferon Alpha-2b in Metastatic Hormone Resistant Prostate Cancer
HCRN-MM91-1
A Phase I/II Study of Carboplatin plus Interferon Alpha-2b in Untreated Multiple Myeloma
HCRN-HOG-10
Phase II Study of Cimetidine in Patients with Metastatic Malignant Melanoma
HCRN-NHL92-1
Phase II Trial of Vincristine, Prednisone, Etoposide and Mitoxantrone in Elderly Patients with Aggressive Histology in Non-Hodgkin’s Lymphoma
HCRN-HOG-13
Phase II Study of High-Dose Cimetidine for Treatment of Metastatic Renal Cell Carcinoma
HCRN-HOG-05
Adjuvant Internal Radiotherapy to the Liver Using Colloidal 32p in Colon Cancer
HCRN-LUN86-1
A Randomized Phase III Study Of Definitive Radiation Therapy With/Without Cisplatinum in Previously Untreated Inoperable Non-Metastatic Non-Small Cell Lung Cancer
HCRN-HOG-01
A Randomized Phase III Study of 5-FU + Cisplatin in Previously Untreated Metastatic Adenocarcinoma of the Colon
HCRN-HOG-02
Phase III Randomized Comparison of Cyclophosphamide vs Cyclophosphamide + Adriamycin + Methotrexate for Stage IV Hormone Resistant Prostatic Cancer
HCRN-NHL88-1
Phase II Trial of Carboplatin in Low-Grade Non-Hodgkin’s Lymphoma
HCRN-HOG-14
Phase II Study of Vinblastine VP-16 (Etoposide), and Cisplatin (VEP) for Patients with Extensive Non-Small Cell Lung Cancer
